-
US commences research on allergic reaction risk in Moderna, Pfizer vaccines
expresspharma
April 08, 2021
Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after vaccinations of Pfizer/BioNTech and Moderna shots.
-
Moderna, Catalent Enter Long-Term Strategic Vax Pact
contractpharma
April 08, 2021
Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.
-
Novavax allows giving COVID-19 vaccine to trial participants on placebo
expresspharma
April 07, 2021
Allowing volunteers to crossover to the active vaccine offers them an incentive to continue in the trials even when other authorised vaccines are available.
-
Valneva reports positive Phase 1/2 data for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001
worldpharmanews
April 07, 2021
Valneva SE announced positive data for Part A of the Phase 1/2 clinical trial of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
-
Novavax commences crossover arms in Covid-19 vaccine trials
pharmaceutical-technology
April 06, 2021
Novavax has announced the start of crossover arms in the ongoing phase IIb South African trial and pivotal phase III UK trial of its Covid-19 vaccine candidate NVX-CoV2373.
-
Hungary issues GMP certificate to Sinopharm’s Covid-19 vaccine
pharmaceutical-technology
April 06, 2021
The Hungarian National Institute of Pharmacy and Nutrition has issued a Good Manufacturing Practice (GMP) certificate to China National Pharmaceutical Group’s (Sinopharm) Covid-19 vaccine.
-
India has not banned exports of COVID-19 vaccines: MEA
expresspharma
April 06, 2021
Asserting that India has not imposed any export ban on anti-coronavirus vaccines, the Ministry of External Affairssaid the country has taken the lead in sending vaccines abroad with over 640 lakh doses supplied to more than 80 countries till now.
-
EU countries consent to share COVID-19 vaccines with member states in need
expresspharma
April 06, 2021
Those countries are Bulgaria, Croatia, Estonia, Latvia and Slovakia. They will also receive their pro-rata share of the total 10 million doses.
-
DCGI expert committee allows clinical trials for third dose of Bharat Biotech’s Covaxin
expresspharma
April 06, 2021
The expert panel of DCGI has permitted Bharat Biotech to give a third dose of Covaxin to a few volunteers in its clinical trials of the COVID-19 vaccine, sources said.
-
Moderna gets USFDA nod for bigger vials of COVID-19 vaccine
expresspharma
April 06, 2021
Moderna said its vaccine can now be supplied in vials containing 11 or 15 doses, and it expected to begin shipping 15-dose vials in coming weeks.